Internal Medicine, Hematology & Oncology · Jackson, MS
NPI
1114188471
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
2500 N State St
Jackson, MS, 39216
Phone (601) 984-5616
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
1,653 services
Medicare patients, 2024
313
Average age 73
Drug cost, 2024
$3.8M
2,911 prescriptions
Company payments, 2025
$4,117
From 50 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John C Henegan Jr. was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 394 times for 135 patients. In total John C Henegan Jr. billed 1,653 services in 22 codes, and Medicare paid $85K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 394 | 135 | $12.03 | $4,739 |
| 99214 Office E&M - Established | Office | 335 | 136 | $66.82 | $22K |
| 99213 Office E&M - Established | Office | 208 | 113 | $44.98 | $9,356 |
| 99215 Office E&M - Established | Office | 164 | 70 | $100.44 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 136 | 48 | $57.40 | $7,806 |
| 99212 Office E&M - Established | Office | 68 | 34 | $27.52 | $1,871 |
| 99231 Hospital E&M - Subsequent | Facility | 56 | 14 | $36.18 | $2,026 |
| 99233 Hospital E&M - Subsequent | Facility | 50 | 29 | $86.09 | $4,304 |
| 99441 Telephone Services | Office | 50 | 35 | $29.21 | $1,460 |
| 99238 Hospital Discharge Management | Facility | 40 | 38 | $58.93 | $2,357 |
| 99205 Office E&M - New | Office | 33 | 33 | $128.45 | $4,239 |
| 99223 Hospital E&M - Initial | Facility | 29 | 28 | $117.61 | $3,411 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 21 | 13 | $22.86 | $480 |
| 99204 Office E&M - New | Office | 21 | 21 | $93.72 | $1,968 |
| 99211 Office E&M - Established | Office | 12 | 11 | $7.50 | $90.04 |
By year: 2022 $73K for 1,109 services; 2023 $66K for 1,059 services; 2024 $85K for 1,653 services.
Medicare prescription drug claims, 2024
In 2024, the drug John C Henegan Jr. prescribed most often to Medicare patients was Abiraterone Acetate, with 391 prescriptions and refills. In total John C Henegan Jr. wrote 2,911 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 391 | 395 | 54 | $593K |
| Prednisone Generic | 343 | 492 | 70 | $1,376 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 177 | 178 | 52 | $3,149 |
| Tamsulosin Hcl Generic | 120 | 231 | 39 | $1,897 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 98 | 103 | 21 | $1,814 |
| Gabapentin Generic | 89 | 132 | 29 | $962 |
| Xtandi Enzalutamide | 84 | 84 | 13 | $889K |
| Amlodipine Besylate Generic | 80 | 228 | 32 | $302 |
| Ondansetron Hcl Generic | 72 | 73 | 41 | $1,546 |
| Oxycodone Hcl Generic | 58 | 58 | 20 | $803 |
| Levothyroxine Sodium Generic | 46 | 107 | 15 | $360 |
| Dexamethasone Generic | 44 | 54 | 25 | $335 |
| Morphine Sulfate Er Morphine Sulfate | 40 | 40 | 15 | $1,366 |
| Omeprazole Generic | 39 | 64 | 12 | $260 |
| Eliquis Apixaban | 37 | 55 | Under 11 | $29K |
Brand drugs: - claims; generic drugs: 2,555 claims; opioid claims: 423.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John C Henegan Jr. $4,117 ($4,117 in general payments such as food, travel and fees) from 50 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $333.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 10 | $333 |
| Novartis Pharmaceuticals Corporation NVS | 17 | $280 |
| Pfizer Inc. PFE | 16 | $267 |
| Incyte Corporation INCY | 16 | $198 |
| Janssen Biotech, Inc. JNJ | 10 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $171 |
| Merck Sharp & Dohme LLC MRK | 8 | $168 |
| Astellas Pharma US Inc 4503.T | 7 | $152 |
| Celgene Corporation BMY | 7 | $149 |
| Abbvie Inc. ABBV | 6 | $148 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.